StonvexLoading…
StonvexStonvexStonvexCore line items from BB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-28 | Annual 2025 2025-02-28 | Annual 2024 2024-02-29 | Annual 2023 2023-02-28 |
|---|---|---|---|---|
Revenue | $549.10M | $534.90M | $759.10M | $526.30M |
Operating Income | $48.30M | $800.00K | $11.00M | $-206.80M |
Net Income | $53.20M | $-79.00M | $-130.20M | $-734.40M |
EPS (Diluted) | $0.09 | $-0.13 | $-0.22 | $-1.35 |
Total Assets | $1.25B | $1.30B | $1.40B | $1.68B |
Total Liabilities | $499.20M | $575.70M | $619.90M | $822.00M |
Cash & Equivalents | $274.70M | $266.70M | $175.10M | $295.70M |
Free Cash Flow OCF − CapEx | $46.50M | $13.40M | $-10.60M | $-269.50M |
Shares Outstanding | 587.43M | 596.23M | 589.23M | 582.16M |